Patent Application
20140345613
The present disclosure relates to an arrangement for a drug delivery device, e.g. an inhaler, such as a dry powder inhaler, and a method for assembling the same.
An inhaler is known from WO 2009/065708 A2, for example.
It is an object of the present disclosure to provide one or more components which facilitate assembling of a drug delivery device and to provide an associated method for assembling a drug delivery device.
This object is achieved by the subject matter of the independent claims. Advantageous embodiments and refinements are subject matter of the dependent claims.
One aspect of the present disclosure relates to an arrangement or system for a drug delivery device, such as an inhaler. The arrangement comprises a support and a connection part. The arrangement may further comprise a spring element, wherein the spring element may be arranged between the support and the connection part. The support comprises a support connection element and the connection part comprises a part connection element. The support connection element and the part connection element are configured to establish a releasable connection to releasably connect the support and the connection part.
An advantage of the present disclosure of the proposed arrangement is that it enables to form a unit from single components like the support and the connection part as well as optionally the spring element. The pre-assembled unit can be handled more easily than the single components as the support and the connection part may be firmly, but releasably, connected to one another. In particular, the spring element may be retained, if appropriate in a biased state, between the support and the connection part. Thus, the spring element may be kept in a reliably biased, e.g. compressed, state and can nevertheless be handled easily as it is retained between connection part and support which are connected to each other. Accordingly, a pre-assembled unit may be formed for the drug delivery device from the recited components of the arrangement when the releasable connection is established. During assembling of the drug delivery device, the releasable connection may be released and the connection part may be moved with respect to the support, for example by means of the spring force of the spring element which may now reduce its bias.
The support may support the spring element. The connection part may form a counter bearing for the spring element. Accordingly, the spring element may be arranged and retained between the support and the connection part.
In an embodiment, a unit is provided, which comprises the arrangement, wherein the releasable connection between the support and the connection part is established.
An aspect of the present disclosure relates to a module. The module may be connectable to the unit recited above, in particular to form the drug delivery device. The module may comprise one or more components to form the drug delivery device together with the components of the arrangement recited further above. For example, the module may comprise a reservoir configured to retain the drug, particularly a plurality of doses thereof, to be dispensed from the device, a dosing mechanism to prepare a dose of drug for dispense, and/or a body to retain further components of the module, etc. The module may comprise at least one release element or more than one release element. The release element may be configured to cooperate with at least one of the support connection element and the part connection element to release the releasable connection when the unit and the module are connected to one another. The release elements may be uniformly distributed in the module. The provision of a release element provides the advantage that the releasable connection can be easily released, without any separate or even external means, just during the regular movement necessary for assembling the unit and the module for the device. Once assembled, the unit and the module may be firmly, preferably irreleasably, connected to each other.
In an advantageous embodiment, the reservoir is arranged at an open end of the module. The reservoir may be filled with drug via an opening which faces the open end of the module. The open end and, particularly, the reservoir may be configured to receive the connection part. The support may be configured to be, e.g. permanently connected to the body. The support may form an outer surface of the device, e.g. the bottom surface.
An embodiment relates to a kit which comprises the unit and the module as described further above.
An embodiment relates to a drug delivery device which comprises the arrangement. The device may comprise the module recited above, which is connected to the arrangement. In the device, the releasable connection between the support and the connection part is not established. Accordingly, the connection part is movable relative to the support. The spring element may be arranged to move the connection part away from the support when the drug delivery device is operated to dispense a dose of the drug. This provides the advantage that the drug can be kept under pressure by the connection part. This facilitates provision of reproducible doses, i.e. a constant dose volume of the doses of drug which are dispensed from the reservoir, over the lifetime of the inhaler. The connection part may form a movable sealing base of the reservoir.
A further aspect of the present disclosure relates to a method of assembling a drug delivery device. Therein, a unit and a module, e.g. as recited further above, are provided. The unit comprises a support and a connection part which are releasably connected to each other. The module comprises a reservoir and an opening communicating with the reservoir. Additionally, the method comprises the step of filling drug into the reservoir via the opening. Thereafter, the unit and the module are connected with each other. The opening of the filled reservoir is closed with the connection part and the releasable connection is released in such a way that the connection part is movable with respect to the support. Closing the opening and the release of the releasable connection may take place simultaneously with the connection between the unit and the module or before the unit is connected to the module, e.g. before a movement between the module and the unit for connecting the unit and the module has been completed. Closing the opening may be enabled by the release of the releasable connection which may render the part connection element movable. Alternatively, the opening may already be closed, before the releasable connection is released, e.g. by moving the connection part into the reservoir before the releasable connection is released. During connection of the module and the unit, the support may be, e.g. firmly and/or irreleasably, connected to a body of the module, within which the reservoir may be formed or retained.
As an advantage, the method allows for easy assembling of a drug delivery device comprising a plurality of mechanically engaged and interacting parts by means of pre-assembled units or modules each, in turn, comprising a plurality of parts itself. Thereby, the unit and the module can be connected with the effect of the releasable connection being released and the connection part being accommodated movably with respect to the support within the reservoir.
In an embodiment, the support comprises a guide feature associated with and, particularly angularly, offset from the support connection element, wherein, when the releasable connection is established, the part connection element is, at least partly, arranged between the support connection element and the guide feature. This geometry may prevent a relative rotation of the support and the connection part, when said parts are releasably connected. Thus, the guide feature may stabilize the unit. Furthermore, the guide feature may guide the relative movement of the connection part and the support when they are connected to form the unit.
In an advantageous embodiment, the support forms the base of the drug delivery device and is arranged at the bottom end.
In an embodiment, the releasable connection is a snap-fit connection. The snap-fit connection is expediently formed by the connection elements. Accordingly, the connection elements may be designed as snap elements or snap means. Each support connection element may mate with a part connection element. The advantage of the configuration as snap-fit connection is the reliable mechanical engagement, whereby the releasable connection can be easily established and released.
In an embodiment, the arrangement comprises a desiccant which may be provided within a desiccator, e.g. a desiccator capsule. The desiccant may be arranged within an interior space delimited by the spring element. This provides for a particular space saving arrangement. The desiccant may avoid moisture induced by agglutination of drug in the reservoir of the device.
In an embodiment, the support connection element and the part connection element are further oriented along a respective axis, preferably along a common axis. The axis may be the longitudinal axis of the drug delivery device. The orientation of the connection elements along the common axis may define the direction along which the module and the unit have to be moved to connect the module and the unit and/or to release the releasable connection, after the unit and the module have been arranged such that the axes of the connection elements have been aligned.
In an advantageous embodiment one of the connection elements may be implemented flexible. In other words, one of the connection elements may be flexible. The other one of the connection elements may be rigid. This enables a simple displacement of the flexible connection element with respect to the other connection element in order to engage or disengage the connection elements and, consequently, to establish or to release the releasable connection, respectively.
In an embodiment, the connection part comprises a main body. The part connection element may comprise an axially oriented bar which is spaced apart from and connected to the main body of the connection part. As an advantage, this geometry may allow for a mechanical stabilization of the releasable connection against external torques, e.g., being applied to the connection part. Furthermore, the bar may provide a guide track for the release element during the connection of the unit and the module. Furthermore, the bar may provide a means for a visual filling level indicator of the device.
In an embodiment, the connection part comprises a seal member. The seal member may be configured to cooperate with a wall of the reservoir, e.g. to seal the reservoir, particularly the opening thereof. The seal member may be configured to form a drug-tight seal in cooperation with the wall of the reservoir. In an advantageous embodiment, the seal member is arranged at the top end of the connection part. The seal member may form the movable sealing base of the reservoir.
In an embodiment, particularly when the releasable connection is established, the flexible one of the support connection element and the part connection element has or provides an exposed surface. The exposed surface may be an oblique, preferably not perpendicular, surface. The exposed surface may have a surface normal defining an acute angle with the axis. The exposed surface may be a plane surface. The exposed surface may be provided by the flexible one of the part connection element and the support connection element. The exposed oblique surface may provide an interaction surface for cooperating with the release element to release the releasable connection.
In an embodiment, the support connection element and the part connection element are arranged and configured such that, when the releasable connection is not established, and the distance between the support connection element and the part connection element is decreased by a relative movement between the support and the connection part, the support connection element and the part connection element engage one another, thereby releasably connecting the support and the connection part. The spring element may be biased during this movement. Establishing and/or releasing the releasable connection may involve flexing the flexible one of the connection elements with respect to the other one of the connection elements.
In an embodiment, the releasable connection, when established, prevents relative movement between the support connection element and the part connection element, whereas the movement would increase the distance between the support connection element and the part connection element.
In an embodiment, when the releasable connection is established, the spring element is biased and disengagement of the support connection element and the part connection element is prevented by the spring force of the biased spring element which keeps the support connection element and the part connection element in abutment. Accordingly, the advantage is the biasing of the spring element and the fixation of the connection part relative to the support by the releasable connection.
In an embodiment, the assembling is carried out by moving the unit and the module axially towards one another, the release element thereby cooperating with the exposed surface of one of the support connection element and the part connection element, e.g. the flexible one of the connection elements. Further movement causes a deflection of the flexible one of the support connection element and the part connection element, thereby releasing the releasable connection, e.g. by disengaging the connection elements.
In an embodiment, the release of the releasable connection triggers a partly release of the biased spring element. The restoring force of the spring element may push the seal member of the connection part against the drug in the reservoir.
In an embodiment, after the releasable connection has been released, the flexible connection element may remain deflected, e.g. due to the release element still acting on the connection element. The deflected connection element may remain connected to the connection part or the support respectively, i.e. it may not be detached, e.g. broken, due to the deflection force acting on the element. Accordingly, there are no loose parts in the device once it was assembled although one of the connection elements may have been considerably deflected during connection of the module and the unit. Loose components in a device may, for example, disturb the visual indication of the filling level.
In an embodiment, one of the connection elements, such as the flexible one of the connection elements, e.g. the support connection element, is implemented hook-like. In other words the respective connection element may comprise a shaft and a projection projecting from the shaft. Provision of a flexible connection element is facilitated in this way. The part connection element may comprise a receiving section in order to receive the projection of the support connection element to establish the releasable connection.
In an embodiment, the support comprises a plurality of support connection elements.
In an embodiment, the connection part comprises a plurality of part connection elements. The part connection elements may, in each case, be configured to mate with a respective one of the support connection elements.
The support connection elements and/or the part connection elements may be uniformly distributed in the circumferential direction on the support or the connection part, respectively. A respective guide feature may be associated with each support connection element.
In an embodiment, a plurality of guide features and/or release elements may be provided. Expediently, part connection elements, support connection elements, guide features, and/or release elements are provided in equal numbers. The respective elements or features are expediently uniformly distributed in the circumferential direction.
Features which are described herein above and below in conjunction with different aspects or embodiments may also apply for other aspects and embodiments. Particularly, features described with respect to the arrangement may apply for the method, the unit and the module and vice versa.
Further features and advantages of the subject matter of this disclosure will become apparent from the following description of the exemplary embodiment in conjunction with the figures, in which:
Like elements, elements of the same kind and identically acting elements may be provided with the same reference numerals in the figures. Additionally, the figures may be not true to scale. Rather, certain features may be depicted in an exaggerated fashion for better illustration of important principles.
The arrangement comprises a support 10 and a connection part 20. The arrangement 1 further comprises a spring element 30. Furthermore, the arrangement comprises a desiccator 50. The parts of the arrangement 1 are arranged and particularly oriented along the axis x-x in the drug delivery device 80 (see
The support 10 has a main body 19. The main body 19 may define a circular shape in plan view. The support 10 may form a boundary of the drug delivery device 80, e.g. its bottom. The support 10 comprises two support connection elements 11. The support connection elements 11 are arranged close to the outer edge of the support 10.
The respective support connection element 11 may protrude from the main body 19 of the support 10 in a direction along the axis, particularly towards the connection part 20. Accordingly, the respective support connection element 11 may mechanically cooperate with the connection part 20. The support connection elements 11 may comprise a shaft 16 and a projection 17 protruding from the shaft 16. The shaft 16 may be oriented axially, whereas the projection 17 may extend in the angular or tangential direction. Particularly, the connection elements are implemented hook-like. The support connection elements 11 may be implemented as snap elements or snap means. A hook-like configuration is particularly expedient for this purpose.
The respective support connection element 11 is flexible, e.g. it may be deflected, such as bent, with respect to the main body 19, expediently in an elastical or plastical fashion but without breaking.
The respective support connection element 11 comprises an oblique surface 18, particularly a surface facing towards the connection part 20. The surface may be plane. The surface has a surface normal which is oblique, particularly not perpendicular, to the axis.
It will be appreciated that the exemplary embodiment relates to two connection elements. However, there may also be just one, or more than two connection elements, such as three or more. Expediently, the number of other features or elements associated with the connection elements which are described further below may be adjusted to correspond to the number of connection elements.
The support 10 furthermore comprises two guide features 12, one associated with each of the support connection elements 11. The respective guide feature 12 may protrude into the axial direction from the main body 19 of the support 10. The respective guide feature 12 further protrudes radially inwardly from a rim 15 which circumferentially delimits the support 10. The rim 15 may protrude axially from the main body 19. The respective guide feature 12 is of reduced length as compared to the associated support connection element 11. The respective guide feature 12 is offset, particularly angularly offset, from the associated support connection element 11. The guide feature 12 associated with one of the support connection elements 11 is arranged closer to that support connection element 11 than to the other support connection element 11. Between the support connection elements 11, a retaining space of the support 10 may be defined, wherein the desiccant 50 and the spring element 30 may be arranged, once the components of the arrangement 1 have been assembled to form the unit 60 as it is depicted in
The support 10 also comprises two spacers 13. The spacers 13 are arranged diametrically opposite to each other. The support 10 furthermore comprises a receiving section 14, e.g. a space radially outwardly delimited by a receiver ring protruding from the main body 19 of the support 10. The receiving section 14 may be designed to receive and retain the desiccator 50, such as by a clamping action.
The connection part 20 comprises a main body 28 and two part connection elements 21. The part connection elements 21 are elongate. The part connection elements 21 are oriented axially. The part connection elements 21 are connected to, but spaced apart from the main body 28. The main body 28 of the connection part 20 has, for example, a cylindrical shape. Of course, it may also have different shapes. The connection part 20 expediently defines a retaining space for receiving the spring element 30 and, if applicable, also the desiccator 50. Accordingly, in the assembled unit 60 said elements can be received within the connection part 20. For this purpose, the main body 28 may define an interior hollow.
The respective part connection element 21 may comprise a bar 22 and a recess 23 provided in the bar 22. The recess 23 may extend in an angular direction into the bar 22.
The support connection elements 11 and the part connection elements 21 are configured to establish a releasable connection between the support 10 and the connection part 20. The releasable connection may be a snap-fit connection. However, a releasable connection of a different type may be applied, e.g. an adhesive connection between the support 10 and the connection part 20. The shaft 16 of the respective support connection element 11 provides a spatial separation of the projection 17 from the main body 19 of the support 10. This facilitates the support connection elements 11 to be formed flexible in order to provide reliable connection elements for the releasable connection. The length of the shaft 16 may be adjusted to provide the required flexibility.
In order to establish the releasable connection of the support 10 and the connection part 20, the recesses 23 of the part connection elements 20 are brought into engagement with the projections 17 of the support connection elements 11. The recesses 23 may be matched to the projections 17 of the support connection elements 11. The recesses 23 are expediently arranged in the lower half of the connection part 20. In other words, the recesses are provided closer to that end of the connection part 20 which faces the support 10, i.e. the bottom end 24, than to the end which is remote from the support, i.e. the top end 25. The distance of the recesses 23 to the bottom end 24 is matched to the length of the shafts 16 of the support connection elements 11.
Furthermore, the part connection elements 21 are disposed diametrically opposite to one another. The same holds for the support connection elements 11. Thereby, the support or part connection elements 11 or 21 are arranged and configured such that one of those connection elements can be mapped onto the other one of those connection elements by moving the former connection element to the position of the latter connection element in the circumferential direction.
The guide features 12 and the spacers 13 are intended to guide the part connection element 21 and the connection part 20, respectively, during the connection of the support 10 and the connection part 20. The geometry of the guide features 12 and/or the spacers 13 may be rectangular, with the longer axis being oriented radially. Additionally the spacers 13 may guide the connection part 20 during the connection of the support 10 and the connection part 20 and also mechanically reinforce the support 10.
The rim 15 is provided with a projection and/or a groove embodied along the circumference of the support 10 which enables a firm and optionally a virus-tight connection to a module 70 (see
The spring element 30 may be a metallic coil spring and is depicted with a multitude of windings. The spring element 30 is arranged between the support 10 and the connection part 20.
The desiccator 50 has a bottom portion 51 having a diameter smaller than that of a top portion 52 of the desiccator 50. The desiccator 50 may be shaped generally like a cylinder. The configuration of the bottom portion 51 is such, that it fits into the corresponding receiving section 14 of the support 10. The top portion 52 is configured to fit into an interior space delimited by the spring element 30. The outer side face of the receiving section 14 of the support 10 may simultaneously delimit the section of the support 10 which receives the spring element 30, which fits externally around or, e.g. in a friction-fit, onto the receiver ring 14. An internal groove (not shown) is arranged at the top of the interior of the connection part 20 for receiving the spring element 30 at a top end 25 of the main body 28 of the connection part 20.
In the embodiments depicted in
The bars 22 may serve as a filling level indication for the filling level of drug in a reservoir 86 of the device 80, Therefore, the bars 22 are implemented to extend longitudinally as far as to the top end 25 of the main body 28. Additionally, the bars 22 aid the assembly of the drug delivery device 80 and particularly provide guiding means (see below). The space between the part connection elements 21 and the main body 28 may, in the assembled drug delivery device 80, receive the wall of the reservoir 86, such that, the main body 28 is arranged within the reservoir 86 and the connection elements are arranged outside of the reservoir 86. The connection elements 21 may, in this way be utilized for a filling level indication of the filling level of drug within the reservoir 86.
Furthermore, the connection part 20 comprises a seal member 40. The seal member 40 may be connected to the main body 28 of the connection part 20, e.g. clamped or snap-fitted to the main body 28. The seal member 40 is arranged at the top of the connection part 20. The seal member 40 may be made of an elastic material in order to effect as a sealing in the drug delivery device 80. The seal member 40 may end flush with the main body 28 of the connection part 20.
The guide features 12 are spaced along the circumference from the support connection elements 11 by a distance which corresponds to a tangential or angular dimension of the bars 22. This configuration facilitates the reception of one bar 22 between the guide feature 12 and the associated support connection element 11.
When the releasable connection is established, the arrangement 1 forms a unit 60, as depicted in
A suitable module 70 is schematically depicted in
The module 70 may comprise a plurality of components which are pre-assembled for the drug delivery device 80. Such components may comprise the reservoir 86 for retaining the drug, a dosing mechanism suitable to extract a dose of drug from the reservoir 86 and position the dose of drug in a standby position in which the dose is ready to be inhaled during an inhalation action performed by a user of the drug delivery device 80. The reservoir 86 of the module 70 expediently has an opening 71 configured to receive the seal member 40 and optionally the main body 28 of the connection part 20. Via the opening 71, drug may be filled into the reservoir 86. The seal member 40 forms a sealed base of the filled reservoir 86 characterized by a drug-tight contact of the seal member 40 with an inner wall of the reservoir 86.
The module 70 and the unit 60 may be provided in the form of a kit for forming a ready-to-use drug delivery device 80, which may be ready for use after the reservoir 86 of the module 70 has been filled with drug and the unit 60 and the module 70 have been connected.
While unscrewing the cap 81 from the body 88 and removing it from the outer cylinder 82 in this way, the dosing pin 83 is filled with a respective dose of drug 85. The suction air flow generated by a user via the mouth piece 89 then transfers the drug 85 from the dosing pin to the user. In this way, a number of doses, e.g. 40 or more, may be delivered by the drug delivery device 80. Thus, the amount of drug 85 in the reservoir 86 is continuously reduced when the drug delivery device 80 is operated repeatedly. Driven by the spring force of the spring element 30, the seal member 40 may be moved within the reservoir 86 and keep the drug 85 within the reservoir 86 under pressure. The filling level of the reservoir 86 can be observed through the window 84, through which the top section, particularly the top edge 27, of the bar 22 may be viewed which moves together with the seal member 40 in the direction towards the top end of the window while the amount of drug 85 in the reservoir 86 continuously decreases. The window 84 is dimensioned and located to cover the total travel range of the bar 22 over the whole service life of the drug delivery device 80, i.e. from a filled reservoir 86 to a reservoir 86 from which the last dose has been dispensed.
Although the connection elements 11 and 21 are not explicitly shown in
A method of assembling the drug delivery device 80 using the unit 60 and the module 70 as described above comprises, firstly, the step of filling of drug 85 into the reservoir 86 via the opening 71 by any suitable means. Afterwards, the module 70 and the unit 60 may be connected.
The connection of the unit 10 and the module 70 is preferably carried out by moving both parts towards each other along the axis, with respect to which both parts have been aligned previously. Thereby, at a certain point during the movement, the opening 71 of the filled reservoir 86 is closed by the seal member 40. Further movement and thereby decreasing the distance between the unit 10 and the module 70, causes the release elements 72 to come into contact with the exposed surfaces 18 of the support connection elements 11.
Further movement against the resilience of the support connection elements 11 causes deflection of the support connection elements 11 due to the longitudinal movement of the release elements 72 being converted into a tangential or angular movement of the projection 17 by means of the release elements 72 sliding along the exposed and expediently oblique surface. The tangential or angular deflection causes bending of the support connection elements 11, thereby separating the projections 17 of the support connection elements 11 from the recesses 23 of the part connection elements 21 and releasing the releasable connection.
As a consequence, after the releasable connection was released, the connection part 20 becomes moveable with respect to the support 10, since the spring element 30 partly relaxes. By means of the spring element 30, the seal member 40 may be moved into and/or kept in contact with the drug 85 in the reservoir 86 and consequently, a mechanical pressure is exerted on the drug 85. To this effect, the pressure effects the trailing or movement of the seal member 40 which forms a movable base of the reservoir 86.
Although it is described above that the support connection element is flexible, the disclosed concept would also work with a flexible part connection element.
The term “drug” as used herein may mean a pharmaceutical formulation containing at least one pharmaceutically active compound, for example for the treatment of obstructive airway or lung diseases such as asthma or chronic obstructive pulmonary disease (COPD), local respiratory tract oedema, inflammation, viral, bacterial, mycotic or other infection, allergies, diabetes mellitus.
The active pharmaceutical compound is preferably selected from the group consisting of active pharmaceutical compounds suitable for inhalation, preferably antiallergenic, antihistamine, anti-inflammatory, antitussive agents, bronchodilators, anticholinergic drugs, and combinations thereof.
The active pharmaceutical compound may for example be chosen from:
an insulin such as human insulin, e.g. a recombinant human insulin, or a human insulin analogue or derivative, a glucagon-like peptide (GLP-1) or an analogue or derivative thereof, or exendin-3 or exendin-4 or an analogue or derivative of exendin-3 or exendin-4;
an adrenergic agent such as a short acting β2-agonists (e.g. Salbutamol, Albuterol, Levosalbutamol, Fenoterol, Terbutaline, Pirbuterol, Procaterol, Bitolterol, Rimiterol, Carbuterol, Tulobuterol, Reproterol), a long acting β2-agonist (LABA, e.g. Arformoterol, Bambuterol, Clenbuterol, Formoterol, Salmeterol), an ultra LABA (e.g. Indacaterol) or another adrenergic agent (e.g. Epinephrine, Hexoprenaline, Isoprenaline (Isoproterenol), Orciprenaline (Metaproterenol));
a glucocorticoid (e.g. Beclometasone, Budesonide, Ciclesonide, Fluticasone, Mometasone, Flunisolide, Betamethasone, Triamcinolone);
an anticholinergic agent or muscarinic antagonist (e.g. Ipratropium bromide, Oxitropium bromide, Tiotropium bromide);
a mast cell stabilizer (e.g. Cromoglicate, Nedocromil);
a xanthine derivative (e.g. Doxofylline, Enprofylline, Theobromine, Theophylline, Aminophylline, Choline theophyllinate);
an eicosanoid inhibitor, such as a leukotriene antagonist (e.g. Montelukast, Pranlukast, Zafirlukast), a lipoxygenase inhibitor (e.g. Zileuton) or a thromboxane receptor antagonist (e.g. Ramatroban, Seratrodast);
a phosphodiesterase type-4 inhibitor (e.g. Roflumilast);
an antihistamine (e.g. Loratadine, Desloratadine, Cetirizen, Levocetirizine, Fexofenadine);
an allergen immunotherapy (e.g. Omalizumab);
a mucolytic (e.g. Carbocisteine, Erdosteine, Mecysteine);
an antibiotic or antimycotic;
or a combination of any two, three or more of the above-mentioned compound classes or compounds (e.g. Budesonide/Formoterol, Fluticasone/Salmeterol, Ipratropium bromide/Salbutamol, Mometasone/Formoterol);
or a pharmaceutically acceptable salt or solvate or esters of any of the above named compounds.
Pharmaceutically acceptable salts are for example acid addition salts and basic salts. Acid addition salts are e.g. a chloride, bromide, iodide, nitrate, carbonate, sulfate, methylsulfate, phosphate, acetate, benzoate, benzenesulfonate, fumarate, malonate, tartrate, succinate, citrate, lactate, gluconate, glutamate, edetate, mesylate, pamoate, pantothenate or a hydroxy-naphthoate salt. Basic salts are for example salts having a cation selected from alkali or alkaline, e.g. Na+, or K+, or Ca2+, or an ammonium ion N+(R1)(R2)(R3)(R4), wherein R1 to R4 independently of each other mean: hydrogen, an optionally substituted C1-C6-alkyl group, an optionally substituted C2-C6-alkenyl group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6-C10-heteroaryl group. Further examples of pharmaceutically acceptable salts are described in “Remington's Pharmaceutical Sciences” 17. ed. Alfonso R. Gennaro (Ed.), Mark Publishing Company, Easton, Pa., U.S.A., 1985 and in Encyclopedia of Pharmaceutical Technology. Pharmaceutically acceptable ester may for example be acetates, propionates, phosphates, succinates or etabonates.
Pharmaceutically acceptable solvates are for example hydrates.
The scope of protection of the invention is not limited to the examples given hereinabove. The invention is embodied in each novel characteristic and each combination of characteristics, which particularly includes every combination of any features which are stated in the claims, even if this feature or this combination of features is not explicitly stated in the claims or in the examples.
| Number | Date | Country | Kind |
|---|---|---|---|
| 11194966.5 | Dec 2011 | EP | regional |
The present application is a U.S. National Phase Application pursuant to 35 U.S.C. §371 of International Application No. PCT/EP2012/075623 filed Dec. 14, 2012, which claims priority to European Patent Application No. 11194966.5 filed Dec. 21, 2011. The entire disclosure contents of these applications are herewith incorporated by reference into the present application.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP2012/075623 | 12/14/2012 | WO | 00 | 6/19/2014 |
